Clinical Trial Update: Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and immunogenicity of the Plasmodium falciparum vaccine candidate FMP012 with AS01B in healthy malaria-naïve adults; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AS01B Adjuvant System (Adjuvant system AS01B)
• FMP012

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria | Phase 1 | Status: COMPLETED